Authors
Mark F. Pyfer, MD, is a board-certified ophthalmic surgeon at Northern Ophthalmic Associates in Jenkintown, Pennsylvania. He is also on the volunteer teaching faculty and medical staff at Wills Eye Hospital and Thomas Jefferson University. This commentary represents his own personal opinion.
Sam Abdelghany, PharmD, is an executive director of oncology pharmacy at Smilow Cancer Hospital at Yale-New Haven Health.
Advertisement
Advertisement
Trending on AJMC
1
“Fraud Pays”: Congressional Hearing Exposes Deep Cracks in Medicare’s Defenses
2
COA’s “Innovation in Practice” Event Covers the Landscape, From AI to CAR T
3
FDA Approves First-in-Class Weekly Anifrolumab Autoinjector for Systemic Lupus Erythematosus
4
CAR Therapies Could Offer New HBV, HIV Treatments
5

